Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Terns Pharmaceuticals, Inc. (TERN)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
31 May 2023
Vignola Mark J.
Chief Financial Officer, Officer
Terns Pharmaceuticals, Inc.
(TERN)
17,656
+130%
9,997
$1.41
$14,095.77
BUY
31 May 2023
Yoon Seokho Bryan
COO and General Counsel, Officer
Terns Pharmaceuticals, Inc.
(TERN)
17,656
+130%
9,997
$1.41
$14,095.77
BUY
31 May 2023
Sundaram Senthil Vel
Chief Executive Officer, Director, Officer
Terns Pharmaceuticals, Inc.
(TERN)
9,770
+27%
2,111
$1.41
$2,976.51
BUY
1 Feb 2023
Yoon Seokho Bryan
COO and General Counsel, Officer
Terns Pharmaceuticals, Inc.
(TERN)
7,659
+0%
3
$1.41
$4.23
BUY
1 Feb 2023
Vignola Mark J.
Chief Financial Officer, Officer
Terns Pharmaceuticals, Inc.
(TERN)
7,659
+0%
3
$1.41
$4.23
BUY
1 Feb 2023
Sundaram Senthil Vel
Chief Executive Officer, Director, Officer
Terns Pharmaceuticals, Inc.
(TERN)
7,659
+0%
3
$1.41
$4.23
BUY
23 Dec 2022
Lu Hongbo
Director
Terns Pharmaceuticals, Inc.
(TERN)
4,340,212
+21%
758,620
$7.25
$5,499,995.00
BUY
23 Dec 2022
Vivo Opportunity, LLC
10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
4,340,212
+21%
758,620
$7.25
$5,499,995.00
BUY
23 Dec 2022
GORDON CARL L
Director, 10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
4,882,854
+2%
137,931
$7.25
$999,999.75
BUY
23 Dec 2022
ORBIMED ADVISORS LLC
Director, 10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
4,882,854
+2%
137,931
$7.25
$999,999.75
BUY
7 Sep 2022
Vivo Opportunity, LLC
10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
3,581,592
+20%
600,000
$3.60
$2,160,000.00
BUY
7 Sep 2022
Lu Hongbo
Director
Terns Pharmaceuticals, Inc.
(TERN)
3,581,592
+20%
600,000
$3.60
$2,160,000.00
BUY
16 Aug 2022
GORDON CARL L
Director, 10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
4,744,923
+349%
3,690,000
$2.42
$8,929,800.00
BUY
16 Aug 2022
ORBIMED ADVISORS LLC
Director, 10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
4,744,923
+349%
3,690,000
$2.42
$8,929,800.00
BUY
12 Aug 2022
Lu Hongbo
Director
Terns Pharmaceuticals, Inc.
(TERN)
2,981,592
+734%
2,624,239
$2.66
$6,980,244.00
BUY
12 Aug 2022
Vivo Opportunity, LLC
10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
2,981,592
+734%
2,624,239
$2.66
$6,980,244.00
BUY
31 May 2022
Yoon Seokho Bryan
COO and General Counsel, Officer
Terns Pharmaceuticals, Inc.
(TERN)
7,656
+100%
7,656
$1.47
$11,254.32
BUY
31 May 2022
Vignola Mark J.
Chief Financial Officer, Officer
Terns Pharmaceuticals, Inc.
(TERN)
7,656
+100%
7,656
$1.47
$11,254.32
BUY
31 May 2022
Sundaram Senthil Vel
Chief Executive Officer, Director, Officer
Terns Pharmaceuticals, Inc.
(TERN)
7,656
+100%
7,656
$1.47
$11,254.32
BUY
9 Feb 2021
GORDON CARL L
Director, 10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
1,516,481
+45%
475,000
$17.00
$8,075,000.00
BUY
9 Feb 2021
ORBIMED ADVISORS LLC
Director, 10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
1,516,481
+45%
475,000
$17.00
$8,075,000.00
BUY
9 Feb 2021
Vivo Capital VIII, LLC
10% Owner
Terns Pharmaceuticals, Inc.
(TERN)
2,036,557
+30%
475,000
$17.00
$8,075,000.00
BUY
9 Feb 2021
Flynn James E
10% Owner, Possible Member of 10% Group
Terns Pharmaceuticals, Inc.
(TERN)
2,382,033
+38%
665,000
$17.00
$11,305,000.00
Home